IN2014DN08394A - - Google Patents

Info

Publication number
IN2014DN08394A
IN2014DN08394A IN8394DEN2014A IN2014DN08394A IN 2014DN08394 A IN2014DN08394 A IN 2014DN08394A IN 8394DEN2014 A IN8394DEN2014 A IN 8394DEN2014A IN 2014DN08394 A IN2014DN08394 A IN 2014DN08394A
Authority
IN
India
Prior art keywords
cell responses
hiv
pathogen
toggle
cytokines
Prior art date
Application number
Other languages
English (en)
Inventor
Riol Marta Ruiz
Christian Brander
Javier Ibarrondo
Original Assignee
Esteve Labor Dr
Fundació Privada Inst De Recerca De La Sida Caixa
Institució Catalana De Recerca I Estudis Avançats
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr, Fundació Privada Inst De Recerca De La Sida Caixa, Institució Catalana De Recerca I Estudis Avançats filed Critical Esteve Labor Dr
Publication of IN2014DN08394A publication Critical patent/IN2014DN08394A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN8394DEN2014 2012-03-23 2013-03-22 IN2014DN08394A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615038P 2012-03-23 2012-03-23
EP12382109 2012-03-23
PCT/EP2013/056110 WO2013139972A1 (fr) 2012-03-23 2013-03-22 Procédé pour surveiller des réponses de lymphocytes t spécifiques du vih

Publications (1)

Publication Number Publication Date
IN2014DN08394A true IN2014DN08394A (fr) 2015-05-08

Family

ID=49221879

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8394DEN2014 IN2014DN08394A (fr) 2012-03-23 2013-03-22

Country Status (9)

Country Link
US (1) US9709577B2 (fr)
EP (1) EP2828656B1 (fr)
JP (1) JP6272820B2 (fr)
CN (1) CN104272108A (fr)
CA (1) CA2868066C (fr)
HK (1) HK1205264A1 (fr)
IN (1) IN2014DN08394A (fr)
MX (1) MX2014011484A (fr)
WO (1) WO2013139972A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777256B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 병원체 감염 세포 독성능 평가 방법
KR101777252B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 prrsv 증식 억제능 평가 방법
CN110308285B (zh) * 2019-07-12 2022-07-26 中国人民解放军军事科学院军事医学研究院 用于预测重度电离辐射损伤死亡的标志物组合
WO2023170189A1 (fr) * 2022-03-09 2023-09-14 Fundacio Privada Institut De Recerca De La Sida-Caixa Procédés de surveillance immunitaire amplifiée pour analyser des réponses de lymphocytes t spécifiques d'un antigène

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
US6656471B1 (en) * 1998-11-17 2003-12-02 Board Of Regents, The University Of Texas System HIV-specific T-cell induction
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
US7323346B2 (en) * 2003-08-14 2008-01-29 The General Hospital Corporation Screening for gestational disorders
EP1767937A1 (fr) * 2005-09-27 2007-03-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé de diagnostic du syndrome de restauration immunitaire (IRS) lié à la tuberculose
DE602007008209D1 (de) * 2006-03-20 2010-09-16 St Vincents Hosp Sydney Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen
WO2008127840A2 (fr) * 2007-03-22 2008-10-23 University Of Iowa Research Foundation Protéines ns5a de flavivirus utilisées dans le traitement du vih
US20090263828A1 (en) * 2008-04-16 2009-10-22 Franco Lori Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
WO2010037408A1 (fr) * 2008-09-30 2010-04-08 Curevac Gmbh Composition comprenant un arnm complexé et un arnm nu pour déclencher ou augmenter une réponse immunostimulante chez un mammifère et utilisations de ladite composition
US9289477B2 (en) * 2011-04-29 2016-03-22 Selecta Biosciences, Inc. Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses

Also Published As

Publication number Publication date
CA2868066A1 (fr) 2013-09-26
CN104272108A (zh) 2015-01-07
CA2868066C (fr) 2019-11-12
US20150057175A1 (en) 2015-02-26
WO2013139972A1 (fr) 2013-09-26
JP2015513100A (ja) 2015-04-30
US9709577B2 (en) 2017-07-18
EP2828656B1 (fr) 2019-09-18
JP6272820B2 (ja) 2018-01-31
HK1205264A1 (en) 2015-12-11
MX2014011484A (es) 2015-09-23
EP2828656A1 (fr) 2015-01-28

Similar Documents

Publication Publication Date Title
MX2018004206A (es) Metodos para diagnosticar enfermedades infecciosas utilizando medios de adsorcion.
EP2708929A3 (fr) Lentille d'imagerie
MX2018003148A (es) Dispositivo y sistema para analizar una muestra, particularmente sangre, asi como metodos de uso de los mismos.
BR112015022073A2 (pt) organização automatizada para classificação de célula
IN2014DN08394A (fr)
EP2667210A3 (fr) Appareil de test pour thyristor
WO2013130274A3 (fr) Alliage d'aluminium avec ajouts de scandium, de zirconium et d'erbium
EP2775162A3 (fr) Plaque de talon composite et suspension pneumatique l'utilisant
CA2902484C (fr) Evaluation d'ecoulement lateral avec retenteur de bande d'essai
WO2015009734A3 (fr) Dosages pour l'activité antimicrobienne et leurs applications
EP2998026A3 (fr) Conception de configuration d'architecture de collecteur
BR112017008654A2 (pt) detector de malária
EP2574937A3 (fr) Détecteur de tension de courant alternatif rapide
MX2015001717A (es) Metodo para la deteccion directa de mycobacterium tuberculosis.
EP2937982A3 (fr) Configuration de commutateur pour un convertisseur de matrice
EP3293254A3 (fr) Dosages au point d'intervention pour détecter le statut d'une infection tuberculeuse
WO2014179737A3 (fr) Dosages et procédés de traitement se rapportant à une carence en vitamine d
EP2557407A3 (fr) Capteur de pression
WO2016029094A8 (fr) Conditionnement d'échantillon et système d'imagerie
EP2519080A3 (fr) Appareil et procédé d'éclairage
WO2020069513A3 (fr) Dispositif d'éclairage de dianostic
WO2016069612A3 (fr) Biomarqueurs pour le diagnostic et la différenciation précoces d'une infection mycobactérienne
EP3516394A4 (fr) Protéines de mycobacterium tuberculosis dans des dosages et dispositifs de diagnostic pour la détection et le diagnostic de la tuberculose
EP2623842A3 (fr) Joint de serrage
WO2016168741A8 (fr) Détection de cytomégalovirus humain